BB&T's shares have now returned 15% year-to-date, following a 2% decline during 2011.
Interested in more on BB&T? See TheStreet Ratings' report card for this stock.
Email. Follow @PhilipvanDoorn
Some beaten up biotech names are finally coming back to life. Here's a look at the technical analysis.